Search - tctmd.com

Displaying 281 - 300 of 309

Sort: Relevancy | Date

Presentation

Use of New-Generation Oral Anticoagulant Agents in Patients Receiving Antiplatelet Therapy After an ACS

Presenter: Andr?s Kom?csi

October 01, 2012

Presentation

Systemic Review and Adjusted Indirect Comparison Meta-analysis of Oral Anticoagulants in A-fib

Presenter: 89964|William Baker

September 10, 2012

Presentation ESC 2012

WOEST: First randomised trial that compares two different regimens with and without aspirin in patients on oral anticoagulant therapy (OAC) undergoing coronary stent placement (PCI)

Presenter: Willem Dewilde

August 28, 2012

News Conference News ESC 2012

WOEST: Clopidogrel Alone Works Best for PCI Patients on Oral Anticoagulants

Yael L. Maxwell

August 28, 2012

News Daily News

Updated Guidelines Support New Antithrombotics as Warfarin Alternatives in A-fib

L.A. McKeown

August 09, 2012

News Daily News

Las Directrices Actualizadas Avalan los Nuevos Antitrombóticos como Alternativas a la Warfarina contra la FA

L.A. McKeown

August 09, 2012

News Daily News

Apixaban Less Costly Than Aspirin for Stroke Prevention in A-Fib at 10 Years

Caitlin E. Cox

July 12, 2012

News Daily News

A los 10 Años el Apixaban resulta Más Barato que la Aspirina para la Prevención de ACV en Pacientes con FA

Caitlin E. Cox

July 12, 2012

News Daily News

Signs Point to Relationship Between Clopidogrel Efficacy, Cigarette Smoking

Yael L. Maxwell

June 20, 2012

News Daily News

Se Publica el PRODIGY: No se observa Ventaja alguna a Largo Plazo con el Clopidogrel

April 03, 2012

News Conference News ACC 2012

Daily Rivaroxaban as Effective as Enoxaparin for Pulmonary Embolism

L.A. McKeown

March 26, 2012

News Daily News

Apixaban Prevents Stroke in A-fib Patients Irrespective of Previous Stroke/TIA

L.A. McKeown

March 12, 2012

News Daily News

El Apixaban Previene el ACV en Pacientes con Fibrilación Auricular con independencia de sus Antecedentes de ACV/AIT

L.A. McKeown

March 12, 2012

Presentation ISET 2012

The Use of Alternative Anticoagulants for Cardiac and Vascular Procedures

Presenter: Gregg W. Stone

January 15, 2012

News Daily News

Meta-Analysis Shows Increased Risk of MI, ACS with Dabigatran

L.A. McKeown

January 09, 2012

News Daily News

Thrombolysis with Immediate Transfer for PCI Safe for Rural STEMI Patients

November 02, 2011

News Daily News

Prothrombin Works as Antidote to Rivaroxaban, Not Dabigatran

L.A. McKeown

September 13, 2011

News Conference News

ESC Congress 2011: Drugs, Devices Work Together

Caitlin E. Cox

September 06, 2011

News Conference News

RUBY-1: Yet Another Novel Anticoagulant Tested in ACS Patients on Antiplatelets

August 31, 2011

News Daily News

One-Month Platelet Reactivity After PCI Key Risk Factor for Future Events

June 13, 2011

Advertisement

Use of New-Generation Oral Anticoagulant Agents in Patients Receiving Antiplatelet Therapy After an ACS

Systemic Review and Adjusted Indirect Comparison Meta-analysis of Oral Anticoagulants in A-fib

WOEST: First randomised trial that compares two different regimens with and without aspirin in patients on oral anticoagulant therapy (OAC) undergoing coronary stent placement (PCI)

WOEST: Clopidogrel Alone Works Best for PCI Patients on Oral Anticoagulants

Updated Guidelines Support New Antithrombotics as Warfarin Alternatives in A-fib

Las Directrices Actualizadas Avalan los Nuevos Antitrombóticos como Alternativas a la Warfarina contra la FA

Apixaban Less Costly Than Aspirin for Stroke Prevention in A-Fib at 10 Years

A los 10 Años el Apixaban resulta Más Barato que la Aspirina para la Prevención de ACV en Pacientes con FA

Signs Point to Relationship Between Clopidogrel Efficacy, Cigarette Smoking

Se Publica el PRODIGY: No se observa Ventaja alguna a Largo Plazo con el Clopidogrel

Daily Rivaroxaban as Effective as Enoxaparin for Pulmonary Embolism

Apixaban Prevents Stroke in A-fib Patients Irrespective of Previous Stroke/TIA

El Apixaban Previene el ACV en Pacientes con Fibrilación Auricular con independencia de sus Antecedentes de ACV/AIT

The Use of Alternative Anticoagulants for Cardiac and Vascular Procedures

Meta-Analysis Shows Increased Risk of MI, ACS with Dabigatran

Thrombolysis with Immediate Transfer for PCI Safe for Rural STEMI Patients

Prothrombin Works as Antidote to Rivaroxaban, Not Dabigatran

ESC Congress 2011: Drugs, Devices Work Together

RUBY-1: Yet Another Novel Anticoagulant Tested in ACS Patients on Antiplatelets

One-Month Platelet Reactivity After PCI Key Risk Factor for Future Events

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content